Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -81.61x is 78% above its 4-year average of -377.49x, near the high end of its 4-year range (-2480.00x–-5.93x).
86.81% above its 12-month average of -618.61x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -576.14x.
INTEREST COVERAGE RATIO
-81.61x
INTEREST COVERAGE RATIO AVG TTM
-618.61x
INTEREST COVERAGE RATIO AVG 3Y
-815.72x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+86.81%
CURRENT VS 3Y AVG
+90.00%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.45x
median of 431 covered companies
CURRENT VS SECTOR MEDIAN
-1397.43%
vs the sector median at left
FibroBiologics, Inc. Common Stock
Market Cap
$2.58M
Interest Coverage Ratio
-81.61x
TTM Avg
-618.61x
3Y Avg
-815.72x
5Y Avg
N/A
Market Cap
$2.58M
Interest Coverage Ratio
-238.27x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.56M
Interest Coverage Ratio
673.25x
TTM Avg
673.25x
3Y Avg
673.25x
5Y Avg
673.25x
Market Cap
$2.61M
Interest Coverage Ratio
-1.05x
TTM Avg
65.98x
3Y Avg
65.98x
5Y Avg
65.98x
Market Cap
$2.64M
Interest Coverage Ratio
-4606.42x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.47M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.33M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| FibroBiologics, Inc. Common Stock (FBLG) | $2.58M | -81.61x | -618.61x | -815.72x | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.58M | -238.27x | N/A | N/A | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.56M | 673.25x | 673.25x | 673.25x | 673.25x |
| Nuwellis, Inc. (NUWE)vs › | $2.61M | -1.05x | 65.98x | 65.98x | 65.98x |
| iSpecimen Inc. (ISPC)vs › | $2.64M | -4606.42x | N/A | N/A | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.47M | N/A | N/A | N/A | N/A |
| Onconetix, Inc. (ONCO)vs › | $2.33M | -8.45x | N/A | N/A | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.33M | N/A | N/A | N/A | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.33M | N/A | N/A | N/A | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.04M | -7.53x | 56.70x | 56.70x | 56.70x |
Interest Coverage
-81.6x
Debt/Equity
0.32
Current Ratio
2.64
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -576.14x |
| 2026-03-31 | -1267.00x |
| 2025-12-31 | -12.70x |
| 2024-12-31 | -618.67x |
| 2024-09-30 | -670.40x |
| 2024-06-30 | -644.80x |
| 2024-03-31 | -862.50x |
| 2023-12-31 | -2480.00x |
| 2023-06-30 | -209.30x |
| 2023-03-31 | -16.78x |
| 2022-12-31 | -5.93x |
| 2022-09-30 | -6.07x |
| 2022-06-30 | -8.55x |
| 2022-03-31 | -8.55x |
